Clinical Trial Update: A Study to Evaluate the Safety of MEDI2338 in Subjects With Chronic Obstructive Pulmonary Disease [Phase 1]

View source ↗

Summary

A Phase 1 study evaluated the safety of MEDI2338 in subjects with chronic obstructive pulmonary disease. The trial has completed and results were posted in 2013…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• MEDI2338

Snippet

Sponsor: MedImmune LLC | Conditions: Chronic Obstructive Pulmonary Disease | Phase 1 | Status: COMPLETED | Results posted: 2013-10-23